Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Variant U1 small nuclear RNA 15 (RNVU1-15) is part of the family of U1 snRNA variants (vU1 snRNAs), non-coding RNAs that are closely related in sequence and function to canonical U1 snRNA. U1 snRNA is a key component of the U1 small nuclear ribonucleoprotein complex (U1 snRNP), which forms part of the spliceosome and is essential in the recognition of the 5′ exon-intron boundary during pre-mRNA splicing[1]. The RNVU1-15 gene is one of numerous U1 snRNA variant genes present in the human genome, typically found in segmental duplication regions, and exhibits high sequence similarity to canonical U1 snRNA[2]. Its specific functional role, expression, and clinical implications are still under investigation. Variability in these loci contributes to genomic diversity and complexity, and may predispose to certain genetic diseases, though it is not considered a classical drug target[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Variant U1 small nuclear RNA 15 (RNVU1-15).